Company Monitoring Page for MannKind

latest headlines for company on cafepharma

Why MannKind Corporation Dipped 4.8% in November
Motley Fool
Tue, 12/5/17 - 11:11 am
Tags:
MannKind, earnings
An Interview With MannKind CEO Michael Castagna
Motley Fool
Sun, 11/19/17 - 09:50 am
Tags:
MannKind, Michael Castagna
Is MannKind's Debt a Ticking Time Bomb?
Motley Fool
Tue, 10/17/17 - 08:25 pm
Tags:
MannKind, debt
3 Drug Stocks That Soared This Week
Motley Fool
Sun, 10/8/17 - 11:26 am
Tags:
Endocyte, PSMA-617, MannKind, Afrezza, Mylan Labs, generics, Teva Pharmaceutical
FDA approves new label language for Afrezza
Greenwich Citizen, CT
Wed, 10/4/17 - 11:17 am
Tags:
FDA, labeling, Afrezza, inhaled insulin, MannKind, diabetes
Why MannKind Stock Started October With a Bang
Motley Fool
Mon, 10/2/17 - 10:14 pm
Tags:
MannKind, inhaled insulin, Afrezza, diabetes
MannKind - Afrezza Scripts Finish August Flat
Seeking Alpha
Sun, 09/10/17 - 11:47 am
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
MannKind posts mixed Q2
Drug Delivery Business News
Tue, 08/8/17 - 11:18 pm
Tags:
MannKind, earnings
MannKind combines inhaled insulin with One Drop’s digital diabetes tech
Drug Delivery Business News
Mon, 08/7/17 - 06:01 pm
Tags:
MannKind, inhaled insulin, One Drop, Afrezza
MannKind: Afrezza Television Ad Debuts; What Investors Need To Know
Seeking Alpha
Fri, 07/21/17 - 10:06 am
Tags:
MannKind, Afrezza, drug ads, diabetes, investors, inhaled insulin
MannKind - Afrezza Scripts Come Back Down After ADA Conference Bump
Seeking Alpha
Mon, 07/3/17 - 09:59 am
Tags:
Afrezza, MannKind, diabetes, inhaled insulin
MannKind: Afrezza Sales See Best Result In More Than A Year
Seeking Alpha
Mon, 06/26/17 - 11:49 am
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
MannKind’s Afrezza needs a big turn. Can reality TV and a new commercial get it done?
Fierce Pharma
Thu, 06/15/17 - 05:15 pm
Tags:
MannKind, Afrezza, diabetes, television ads, drug marketing
MannKind Scripts Not Helping Cash Situation
Seeking Alpha
Tue, 06/13/17 - 04:13 pm
Tags:
MannKind, Afrezza, diabetes, inhaled insulin
MannKind inks deal to bring inhaled insulin to Brazil
Drug Delivery Business News
Thu, 06/1/17 - 02:48 pm
Tags:
MannKind, Brazil, diabetes, inhaled insulin, Afrezza
One Drop, MannKind ink partnership for connected, inhaled diabetes tech
Drug Delivery Business News
Mon, 05/8/17 - 11:29 am
Tags:
One Drop, MannKind, inhaled insulin, diabetes, devices, Afrezza
MannKind Hopes To Reverse Fortunes With Television Show
Seeking Alpha
Wed, 05/3/17 - 02:17 pm
Tags:
MannKind, television ads, diabetes, type 2 diabetes, DTC advertising
Is MannKind Corporation Getting Ready to Sell?
Motley Fool
Mon, 04/10/17 - 10:00 pm
Tags:
MannKind, M&A, SEC
MannKind: Afrezza Sales Remain Low As Q1 Comes To A Close
Seeking Alpha
Mon, 03/27/17 - 10:32 pm
Tags:
MannKind, Afrezza, inhaled insulin, diabetes
Could MannKind Corporation's Marketing Blitz Pay Off?
Motley Fool
Wed, 03/22/17 - 09:59 am
Tags:
MannKind, Afrezza, diabetes, inhaled insulin, Sanofi, drug ads

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.